171 related articles for article (PubMed ID: 34772446)
1. Induction of remission in chronic urticaria by immunotherapy using immunoglobulin/histamine complex (Histobulin™): a case report.
Kim HS; Noh G
Allergy Asthma Clin Immunol; 2021 Nov; 17(1):116. PubMed ID: 34772446
[TBL] [Abstract][Full Text] [Related]
2. Effects of the immunoglobulin/histamine complex on panic disorder concurrent with chronic spontaneous urticaria: a case report.
Kim HS; Noh G
J Med Case Rep; 2023 Jul; 17(1):341. PubMed ID: 37501211
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy using Histobulin™ in psoriasis: A case report.
Kim HS; Noh G
Clin Case Rep; 2022 May; 10(5):e05831. PubMed ID: 35592052
[TBL] [Abstract][Full Text] [Related]
4. Intradermal Immunoglobulin E (IgE) Injection in a Specific Interval With Emollient in the Control of Chronic Idiopathic Urticaria and Allergic Rhinitis.
Sumi FR; Bhuiyan MAKA; Mukit MA; Shamim SMA; Tabassum Orthy R; Jesmin S
Cureus; 2023 Nov; 15(11):e48358. PubMed ID: 38060717
[TBL] [Abstract][Full Text] [Related]
5. Immunological effects and potential mechanisms of action of autologous serum therapy in chronic spontaneous urticaria.
Yu L; Buttgereit T; Stahl Skov P; Schmetzer O; Scheffel J; Kocatürk E; Zawar V; Magerl M; Maurer M
J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1747-1754. PubMed ID: 31025425
[TBL] [Abstract][Full Text] [Related]
6. Improved FcεRI-Mediated CD203c Basophil Responsiveness Reflects Rapid Responses to Omalizumab in Chronic Spontaneous Urticaria.
Oda Y; Fukunaga A; Washio K; Imamura S; Mizuno M; Hatakeyama M; Ogura K; Nishigori C
J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1166-1176.e8. PubMed ID: 32898709
[TBL] [Abstract][Full Text] [Related]
7. Omalizumab therapy for chronic spontaneous urticaria: the Israeli experience.
Rottem M; Segal R; Kivity S; Shamshines L; Graif Y; Shalit M; Kessel A; Panasoff J; Cohen S; Toubi E; Agmon-Levin N
Isr Med Assoc J; 2014 Aug; 16(8):487-90. PubMed ID: 25269339
[TBL] [Abstract][Full Text] [Related]
8. Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: a retrospective clinical analysis.
Metz M; Ohanyan T; Church MK; Maurer M
J Dermatol Sci; 2014 Jan; 73(1):57-62. PubMed ID: 24060603
[TBL] [Abstract][Full Text] [Related]
9. How to Treat Patients with Chronic Spontaneous Urticaria with Omalizumab: Questions and Answers.
Türk M; Carneiro-Leão L; Kolkhir P; Bonnekoh H; Buttgereit T; Maurer M
J Allergy Clin Immunol Pract; 2020 Jan; 8(1):113-124. PubMed ID: 31374358
[TBL] [Abstract][Full Text] [Related]
10. An observational study on the efficacy of single injection of omalizumab in the treatment of chronic spontaneous urticaria.
Lal Vijayalal S; Arora S; Dabas R; Janney MS; Jankal Basavarajappa S; Das NM
Dermatol Ther; 2020 Nov; 33(6):e14397. PubMed ID: 33040395
[TBL] [Abstract][Full Text] [Related]
11. Predictive features associated with chronic spontaneous urticaria recurrence.
Toubi E; Vadasz Z
J Dermatol; 2021 Nov; 48(11):1786-1788. PubMed ID: 34519085
[TBL] [Abstract][Full Text] [Related]
12. Use of Dapsone in the Treatment of Chronic Idiopathic and Autoimmune Urticaria.
Liang SE; Hoffmann R; Peterson E; Soter NA
JAMA Dermatol; 2019 Jan; 155(1):90-95. PubMed ID: 30476976
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of omalizumab treatment for pediatric chronic spontaneous urticaria: A multi-center retrospective case series.
Ari A; Levy Y; Segal N; Maoz-Segal R; Benor S; Broides A; Horev A; Epstein-Rigbi N; Agmon-Levin N; Marcus N
Pediatr Dermatol; 2020 Nov; 37(6):1051-1054. PubMed ID: 32951239
[TBL] [Abstract][Full Text] [Related]
14. Chronic autoimmune urticaria in children.
Dodig S; Richter D
Acta Dermatovenerol Croat; 2008; 16(2):65-71. PubMed ID: 18541101
[TBL] [Abstract][Full Text] [Related]
15. The clinical response to omalizumab in chronic spontaneous urticaria patients is linked to and predicted by IgE levels and their change.
Ertas R; Ozyurt K; Atasoy M; Hawro T; Maurer M
Allergy; 2018 Mar; 73(3):705-712. PubMed ID: 29083482
[TBL] [Abstract][Full Text] [Related]
16. In chronic spontaneous urticaria, IgE against staphylococcal enterotoxins is common and functional.
Altrichter S; Hawro T; Liedtke M; Holtappels G; Bachert C; Skov PS; Maurer M
Allergy; 2018 Jul; 73(7):1497-1504. PubMed ID: 29315616
[TBL] [Abstract][Full Text] [Related]
17. Eosinopenia, in Chronic Spontaneous Urticaria, Is Associated with High Disease Activity, Autoimmunity, and Poor Response to Treatment.
Kolkhir P; Church MK; Altrichter S; Skov PS; Hawro T; Frischbutter S; Metz M; Maurer M
J Allergy Clin Immunol Pract; 2020 Jan; 8(1):318-325.e5. PubMed ID: 31472293
[TBL] [Abstract][Full Text] [Related]
18. IL-24 is a common and specific autoantigen of IgE in patients with chronic spontaneous urticaria.
Schmetzer O; Lakin E; Topal FA; Preusse P; Freier D; Church MK; Maurer M
J Allergy Clin Immunol; 2018 Sep; 142(3):876-882. PubMed ID: 29208545
[TBL] [Abstract][Full Text] [Related]
19. Presence of IgE Autoantibodies Against Eosinophil Peroxidase and Eosinophil Cationic Protein in Severe Chronic Spontaneous Urticaria and Atopic Dermatitis.
Sánchez J; Sánchez A; Munera M; Garcia E; Lopez JF; Velásquez-Lopera M; Cardona R
Allergy Asthma Immunol Res; 2021 Sep; 13(5):746-761. PubMed ID: 34486259
[TBL] [Abstract][Full Text] [Related]
20. Co-occurrence of IgE and IgG autoantibodies in patients with chronic spontaneous urticaria.
Asero R; Marzano AV; Ferrucci S; Lorini M; Carbonelli V; Cugno M
Clin Exp Immunol; 2020 Jun; 200(3):242-249. PubMed ID: 32115683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
